NIAID Banner Logo Image

Opportunistic Infections Citation List:

November 25, 2009 -December 8, 2009

OPPORTUNISTIC PROTOZOA COMPOUNDS (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma])

1. 4-Bromophenacyl Bromide Specifically Inhibits Rhoptry Secretion during Toxoplasma Invasion.

Ravindran S, Lodoen MB, Verhelst SH, Bogyo M, Boothroyd JC.

PLoS One. 2009 Dec 2;4(12):e8143.PMID: 19956582 [PubMed - in process]

ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

2. Fluconazole analogues containing 2H-1,4-benzothiazin-3(4H)-one or 2H-1,4-benzoxazin-3(4H)-one moieties, a novel class of anti-Candida agents.

Borate HB, Maujan SR, Sawargave SP, Chandavarkar MA, Vaiude SR, Joshi VA, Wakharkar RD, Iyer R, Kelkar RG, Chavan SP, Kunte SS.

Bioorg Med Chem Lett. 2009 Dec 4. [Epub ahead of print]PMID: 19963383 [PubMed - as supplied by publisher]

3. High Potency and Broad-Spectrum Antimicrobial Peptides Synthesized via Ring-Opening Polymerization of alpha-Aminoacid-N-carboxyanhydrides.

Zhou C, Qi X, Li P, Chen WN, Mouad L, Chang MW, Leong SS, Chan-Park MB.

Biomacromolecules. 2009 Dec 3. [Epub ahead of print]PMID: 19957992 [PubMed - as supplied by publisher]

4. Novel neofusapyrones isolated from Verticillium dahliae as potent antifungal substances.

Honma M, Kudo S, Takada N, Tanaka K, Miura T, Hashimoto M.

Bioorg Med Chem Lett. 2009 Dec 3. [Epub ahead of print]PMID: 19962895 [PubMed - as supplied by publisher]

5. Synthesis and antimicrobial activity of some new N-acyl substituted phenothiazines.

Bansode TN, Shelke JV, Dongre VG.

Eur J Med Chem. 2009 Dec;44(12):5094-8. Epub 2009 Jul 16.PMID: 19651462 [PubMed - in process]

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

6. Synthesis and Structure-activity Relationships of Antitubercular 2-Nitroimidazooxazines Bearing Heterocyclic Side Chains.

Sutherland, H.S., A. Blaser, I. Kmentova, S.G. Franzblau, B. Wan, Y. Wang, Z. Ma, B.D. Palmer, W.A. Denny, and A.M. Thompson

J Med Chem, 2009; PMID[19968290]

7. 5-Nitrothiazolylthiosemicarbazones: Synthesis and antimycobacterial evaluation against tubercular and non-tubercular mycobacterial species.

Sriram, D., P. Yogeeswari, P. Senthilkumar, and D. Sangaraju

J Enzyme Inhib Med Chem, 2009; PMID[19929750]

8. Synthesis and Structure-Activity Studies of Biphenyl Analogues of the Tuberculosis Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1, 3]oxazine (PA-824).

Palmer, B.D., A.M. Thompson, H.S. Sutherland, A. Blaser, I. Kmentova, S.G. Franzblau, B. Wan, Y. Wang, Z. Ma, and W.A. Denny

J Med Chem, 2009; PMID[19928920]

9. [R207910 (TMC207): A new antibiotic for the treatment of tuberculosis.].

Lounis, N., J. Guillemont, N. Veziris, A. Koul, V. Jarlier, and K. Andries

Med Mal Infect, 2009; PMID[19954909]

10. Activity of the phenothiazine methdilazine alone or in combination with isoniazid or streptomycin against Mycobacterium tuberculosis in mice

Dutta, N.K., K. Mazumdar, A. DasGupta, and S.G. Dastidar

J Med Microbiol, 2009. 58(Pt 12): p. 1667-8; PMID[19696152]

Citations from the ISI Web of Knowledge Listings for O.I.

11. Fragment-based discovery of selective inhibitors of the Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.

Rawls, K.A., P.T. Lang, J. Takeuchi, S. Imamura, T.D. Baguley, C. Grundner, T. Alber, and J.A. Ellman

Bioorganic & Medicinal Chemistry Letters, 2009. 19(24): p. 6851-6854; PMID[ISI:000271724200005]

12. Novel Pthalazinyl Derivatives: Synthesis, Antimycobacterial Activities, and Inhibition of Mycobacterium Tuberculosis Isocitrate Lyase Enzyme.

Sriram, D., P. Yogeeswari, P. Senthilkumar, S. Dewakar, N. Rohit, B. Debjani, P. Bhat, B. Veugopal, V.V.S. Pavan, and H.M. Thimmappa

Medicinal Chemistry, 2009. 5(5): p. 422-433; PMID[ISI:000271619300004]

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2023